Picture of Perpetua Medical AB (publ) logo

PERP B — Perpetua Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Pharmacolog I Uppsala Intends To Implement Cost Reductions

Oct 2 (Reuters) - Pharmacolog I Uppsala AB (publ)
 PHLOGb.ST :
    * INTENDS TO IMPLEMENT COST REDUCTIONS
    * INITIATING A COST-SAVING PROGRAM THAT WILL SIGNIFICANTLY
REDUCE
ONGOING OPERATING COSTS WHILE STREAMLINING COMPANY ORGANIZATION
TO SUPPORT EXISTING CUSTOMERS AND EXTERNAL DISTRIBUTORS
    * IMPLEMENTATION OF COST-REDUCING MEASURES WILL START
IMMEDIATELY
AND WILL BE FULLY IMPLEMENTED BY JANUARY 2024
    * AT FULL EFFECT, MEASURES WILL REDUCE OPERATING COSTS BY AT
LEAST
35% COMPARED TO OPERATING COSTS OF FULL YEAR 2022, THIS
CORRESPONDS TO A SUM OF AT LEAST SEK 10 MILLION
    * DIRECT SALES EFFORTS HAVE NOT MET EXPECTATIONS OF COMPANY
AND
ITS SHAREHOLDERS

Source text for Eikon:  ID: 
Further company coverage:  PHLOGb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

Recent news on Perpetua Medical AB (publ)

See all news